Issue of Performance Share Rights
Capital Change Notice
Notice of issue of Share Rights under Hallenstein Glasson Holdings Limited’s Long Term Incentive Plan
This notice is given under the NZX Listing Rules 3.13.1 and relates to the issue of performance share rights which are
convertible into fully paid ordinary shares in Hallenstein Glasson Holdings Limited should certain vesting criteria be met
under the Hallenstein Glasson Holdings Limited Long Term Incentive Plan (LTI Plan).
Section 1: Issuer information
Name of issuer Hallenstein Glasson Holdings Limited
NZX ticker code HLG
Class of financial product
Unquoted performance share rights convertible into
fully paid ordinary shares in Hallenstein Glasson
Holdings Limited (Share Rights).
ISIN (If unknown, check on NZX website) N/A
Currency NZD
Section 2: Capital change details
Number issued/acquired/redeemed 36,873
Nominal value (if any) N/A
Issue/acquisition/redemption price per security Share Rights issued for nil consideration
Nature of the payment (for example, cash or other
consideration)
No amount is payable for the grant of Share Rights
under the LTI Plan.
Amount paid up (if not in full) N/A
Percentage of total class of Financial Products
issued/acquired/redeemed/ (calculated on the
number of Financial Products of the Class,
excluding any Treasury Stock, in existence)
1
The Share Rights comprise 100% of the financial
products of that class.
For an issue of Convertible Financial Products or
Options, the principal terms of Conversion (for
example the Conversion price and Conversion
date and the ranking of the Financial Product in
relation to other Classes of Financial Product) or
the Option (for example, the exercise price and
exercise date)
Each Share Right granted under the LTI Plan
entitles the holder to acquire one fully paid
ordinary share in Hallenstein Glasson Holdings
Limited, subject to the Share Right vesting.
100% of vesting is subject to Hallenstein Glasson
Holdings Limited’s financial performance
assessed against its Earnings Per Share
Compound Annual Growth Rate over the three-
year performance period between 2 August 2024
and 1 August 2027 (Performance Period).
Share Rights will lapse where the performance
condition is not met.
Share Rights will also lapse where the holder
ceases to be employed by Hallenstein Glasson
Holdings Limited before the end of the
Performance Period.
There is no amount payable by holders either on
grant or exercise of the Share Rights.
Reason for issue/acquisition/redemption and
specific authority for issue/acquisition/redemption/
(the reason for change must be identified here)
Issue of Share Rights to the Group Chief Executive
Officer to be converted into Ordinary Shares in
Hallenstein Glasson Holdings Limited upon the
satisfaction of certain conditions in accordance with
the LTI Plan.
1
The percentage is to be calculated immediately before the issue, acquisition, redemption or Conversion.
Authorised by resolutions of the Board dated 31
October 2024.
Total number of Financial Products of the Class
after the issue/acquisition/redemption/Conversion
(excluding Treasury Stock) and the total number
of Financial Products of the Class held as
Treasury Stock after the
issue/acquisition/redemption.
36,873 Share Rights (nil Share Rights held as
treasury stock)
In the case of an acquisition of shares, whether
those shares are to be held as treasury stock
N/A
Specific authority for the issue, acquisition, or
redemption, including a reference to the rule
pursuant to which the issue, acquisition, or
redemption is made
Board resolution dated 31 October 2024 pursuant to
NZX Listing Rule 4.6.1
Terms or details of the issue, acquisition, or
redemption (for example: restrictions, escrow
arrangements)
The holder of the Share Rights has the right to be
issued or transferred the applicable number of
Ordinary Shares in Hallenstein Glasson Holdings
Limited for nil cash consideration 10 business days
after the final results announcement for Hallenstein
Glasson Holdings Limited’s 2027 financial year is
released in September 2027, provided:
the relevant performance condition noted above
is met; and
the holder remains in employment with
Hallenstein Glasson Holdings Limited at the end
of the Performance Period as noted above.
Share Rights will lapse where the above conditions
are not met.
Share Rights are not transferrable and may not be
encumbered, nor do they convey any voting or
distribution rights in any existing shares.
Date of issue 31 October 2024
Section 3: Authority for this announcement and contact person
Name of person
authorised to make this
announcement
Cameron Alderton
Contact person for this announcement Cameron Alderton
Contact phone number 022 394 5785
Contact email address cameron@glassons.com
Date of release through MAP
1 November 2024
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.
Other issuers discussed similar conditions around this time
Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.
- GXH — Green Cross Health Limited: Capital Change Notice - Issue of Performance Share Rights2024-11-28
“Capital Change Notice Notice of issue of Ordinary Shares This notice is given under the NZX Listing Rules 3.13.1 and relates to the issue of Performance Share Rights (“PSRs”) under Green Cross Health Limited’s (“GXH”) Performance Share Rights Scheme (“Scheme”).…”
- HGH — Heartland Group Holdings Limited: Notification of Allotment of Securities2024-09-19
“Capital Change Notice Section 1: Issuer information Name of issuer Heartland Group Holdings Limited NZX ticker code HGH Class of financial product Ordinary shares ISIN (If unknown, check on NZX website) NZHGHE0007S9 Currency NZD Section 2: Capital change details Numbe…”
- ALF — Allied Farmers Limited: Results of Allied Farmers Limited Annual Meeting2024-11-19
“shares on the vesting and exercise of those performance rights, to Richard Milsom under the rules of the Company’s Long Term Incentive Plan. That approval be given for the issue of such number of performance rights during the financial year ending 30 June 2027 equivalent t…”